Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
126.635 0.55 (0.44%)

NAV as on 18 Oct, 2017

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
FUND FAMILY : SBI Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Sep 29, 17)
Equity Sector Value
(Rs cr)
Assets %
Divis Labs Pharmaceuticals 81.50 10.25
Cipla Pharmaceuticals 80.07 10.07
Aurobindo Pharm Pharmaceuticals 74.11 9.32
Strides Shasun Pharmaceuticals 63.29 7.96
Dr Reddys Labs Pharmaceuticals 44.37 5.58
Natco Pharma Pharmaceuticals 39.99 5.03
Cadila Health Pharmaceuticals 37.37 4.70
Alkem Lab Pharmaceuticals 36.58 4.60
Torrent Pharma Pharmaceuticals 35.22 4.43
Thyrocare Techn Services 32.52 4.09
Sector Allocation (Sep 29, 17)
  Sector   % 1-Year
High Low

Pharmaceuticals

86.46 0.00 0.00

Services

9.52 0.00 0.00
Asset Allocation (%) (Sep 29, 17)
Class
%

Equity

95.98

Others / Unlisted

0.03

Debt

0.00

Mutual Funds

N.A

Money Market

4.07

Cash / Call

-0.08

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

43.18

Top 10

66.03
Sectors
%

Top 3

95.98
Sections
Follow us on
Available On